CYPHERPUNK TECHNOLOGIES INC. Prepaid Expense and Other Assets, Current
CYPHERPUNK TECHNOLOGIES INC. (CYPH) had Prepaid Expense and Other Assets, Current of $539.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-12
- 2026-06-30: Prepaid Expense and Other Assets, Current $539.00K.
- 2026-03-31: Prepaid Expense and Other Assets, Current $768.00K.
- 2025-12-31: Prepaid Expense and Other Assets, Current $40.00K.
- 2025-09-30: Prepaid Expense and Other Assets, Current $69.00K.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2026-06-30 | $539.00K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $768.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $40.00K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $69.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $292.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $446.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $86.00K 10-K · filed 2026-03-16 |
| 2024-09-30 | $209.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $354.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $526.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $183.00K 10-K · filed 2025-03-26 |
| 2023-09-30 | $265.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $419.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $590.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $351.00K 10-K · filed 2024-03-18 |
| 2022-09-30 | $374.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $428.00K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $491.00K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $769.00K 10-K · filed 2023-03-24 |
| 2021-09-30 | $271.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $264.00K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $266.00K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $130.00K 10-K · filed 2022-03-11 |
| 2020-09-30 | $217.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $212.00K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $272.00K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $165.00K 10-K · filed 2021-03-12 |
| 2019-09-30 | $210.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $211.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $159.00K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $202.00K 10-K · filed 2020-03-16 |
| 2018-09-30 | $191.00K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $608.00K 10-Q · filed 2018-08-08 |
| 2018-03-31 | $289.00K 10-Q/A · filed 2018-08-08 |
| 2017-12-31 | $177.00K 10-K · filed 2019-04-01 |
| 2017-09-30 | $404.00K 10-Q · filed 2017-11-13 |
| 2017-06-30 | $382.00K 10-Q · filed 2017-08-11 |
| 2017-03-31 | $319.00K 10-Q · filed 2017-05-12 |
| 2016-12-31 | $183.00K 10-K · filed 2018-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |